1. Home
  2. BON vs LTRN Comparison

BON vs LTRN Comparison

Compare BON & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bon Natural Life Limited

BON

Bon Natural Life Limited

N/A

Current Price

$1.05

Market Cap

9.1M

Sector

Health Care

ML Signal

N/A

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

N/A

Current Price

$0.28

Market Cap

10.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BON
LTRN
Founded
2006
2013
Country
China
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1M
10.0M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
BON
LTRN
Price
$1.05
$0.28
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $17.50
AVG Volume (30 Days)
8.9K
★ 166.9K
Earning Date
09-23-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 18.65
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$385.87
N/A
Revenue Next Year
$15.63
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.95
$0.36
52 Week High
$1.94
$4.34

Technical Indicators

Market Signals
Indicator
BON
LTRN
Relative Strength Index (RSI) 38.84 20.94
Support Level $0.97 N/A
Resistance Level $1.17 $0.84
Average True Range (ATR) 0.04 0.08
MACD -0.01 -0.00
Stochastic Oscillator 47.59 0.07

Price Performance

Historical Comparison
BON
LTRN

About BON Bon Natural Life Limited

Bon Natural Life Ltd focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by its customers. It has developed four technology platforms for large-scale separation, safety improvement, activity enhancement, and functional compounding of natural products. The company's offerings include Fragrance compounds, Health supplements, and Bioactive food ingredients. The company generates revenue from the sale of its products, the majority derived from the sale of Fragrance compounds, which include natural compounds extracted from plants for cosmetic applications.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Share on Social Networks: